Gastroenteropancreatic neuroendocrine tumors: new insights in the diagnosis and therapy. - Wikidata - wikimedia - TriplyDB

Gastroenteropancreatic neuroendocrine tumors: new insights in the diagnosis and therapy.

Gastroenteropancreatic neuroendocrine tumors: new insights in the diagnosis and therapy.

http://www.wikidata.org/entity/Q37962416

about

Diagnosis and prediction of neuroendocrine liver metastases: a protocol of six systematic reviews.Nuclear medicine imaging of gastro-entero-pancreatic neuroendocrine tumors. The key role of cellular differentiation and tumor grade: from theory to clinical practice.Ectopic acromegaly due to growth hormone releasing hormone.Pancreatic Neuroendocrine Neoplasms: Basic Biology, Current Treatment Strategies and Prospects for the Future.Well-differentiated pancreatic neuroendocrine tumors: from genetics to therapy.Diagnostic performance of Gallium-68 somatostatin receptor PET and PET/CT in patients with thoracic and gastroenteropancreatic neuroendocrine tumours: a meta-analysis.Novel molecular targets for the treatment of gastroenteropancreatic endocrine tumors: answers and unsolved problems Metachronous appearance of second malignancies in medullary thyroid carcinoma (MTC) patients: a diagnostic challenge and brief review of the literature.Guidelines for biomarker testing in gastroenteropancreatic neuroendocrine neoplasms: a national consensus of the Spanish Society of Pathology and the Spanish Society of Medical Oncology.Investigational drugs targeting somatostatin receptors for treatment of acromegaly and neuroendocrine tumors.PI3K/Akt/mTOR signaling in medullary thyroid cancer: a promising molecular target for cancer therapy.Solitary hypervascular liver metastasis from neuroendocrine tumor mimicking hepatocellular cancer: All that glitters is not gold Well-Differentiated Neuroendocrine Tumour of the Extrahepatic Bile Duct: a Case Report with Review of Literature.PI3K/AKT Pathway and Its Mediators in Thyroid Carcinomas.Valproic acid induces NET cell growth arrest and enhances tumor suppression of the receptor-targeted peptide-drug conjugate via activating somatostatin receptor type II.IGF-IEc expression is increased in secondary compared to primary foci in neuroendocrine neoplasms.Management of neuroendocrine tumors of unknown primary.Patient-derived xenograft in zebrafish embryos: a new platform for translational research in neuroendocrine tumors.'Open-and-close' pituitary surgery in an acromegalic man presenting with excessive sweatiness.Somatostatin analogs in the treatment of neuroendocrine tumors: current and emerging aspects.Secondary malignancy in patients with sporadic neuroendocrine neoplasia.Initial impact of a systematic multidisciplinary approach on the management of patients with gastroenteropancreatic neuroendocrine tumor.HDAC-Linked "Proliferative" miRNA Expression Pattern in Pancreatic Neuroendocrine Tumors

P2860

Q35074944-B25A0852-3CA3-4F8E-AA83-6B53481E924E Q36084862-78626988-9E7E-47A4-906E-DE1F4CE101A3 Q36557139-3FB76C59-514E-4988-92BE-D9719E73727B Q37631597-92359CA9-D651-49E0-9878-8F73E809EA36 Q37981893-4805EC2E-36E0-4FB1-9849-ECCA9982B071 Q37986605-26D2CF04-66B9-4E0F-9D19-F3D46D028E56 Q38076275-A4ACE080-F014-4977-B61B-319B96FA5B95 Q38100936-DB16A970-8C3F-494D-9F08-8DBF21AE2C85 Q38113157-35C2BC91-C6C5-49F2-8302-F7578C4AB3FD Q38233686-B65B9F06-E4A9-41AA-B3F8-20B803B61DE7 Q38239229-407D5ED9-4416-47F7-A108-2011785F1F43 Q38318787-BE094CE9-3E6F-42CD-A114-4F8F8902B289 Q38455236-D386A5CF-7001-43E4-8ADF-3D084B435B18 Q38644584-D8F0EF92-0465-458F-B003-2DB5BAEAC71E Q38849324-5658ABEF-1DE2-4D4B-B49F-071E763FB95A Q46579680-8F1E57CA-505F-4B4F-96BD-5027AF042D8D Q47589718-AD5F66E3-C86E-4755-A5C6-0CAC98F9157F Q48132665-A998944C-6075-4AAE-9F55-A8842680880F Q48685321-A732EE63-12B5-42BC-9DF4-30FBA61505F6 Q50079728-69CF0042-ECC3-4F9B-9912-4A14819158C3 Q51263169-BAC220F7-5329-4D5D-BFC6-442C923A4A12 Q53114629-305F36C9-8B23-480A-A48F-DC019D13419B Q57823913-83A4260B-28B8-41A6-86A1-B9DE86344905

P2860

Gastroenteropancreatic neuroendocrine tumors: new insights in the diagnosis and therapy.

http://www.wikidata.org/entity/Q37962416

description

2011 nî lūn-bûn

@nan

2011年の論文

@ja

2011年学术文章

@wuu

2011年学术文章

@zh-cn

2011年学术文章

@zh-hans

2011年学术文章

@zh-my

2011年学术文章

@zh-sg

2011年學術文章

@yue

2011年學術文章

@zh

2011年學術文章

@zh-hant

name

Gastroenteropancreatic neuroendocrine tumors: new insights in the diagnosis and therapy.

@en

Gastroenteropancreatic neuroendocrine tumors: new insights in the diagnosis and therapy.

@nl

type

label

Gastroenteropancreatic neuroendocrine tumors: new insights in the diagnosis and therapy.

@en

Gastroenteropancreatic neuroendocrine tumors: new insights in the diagnosis and therapy.

@nl

prefLabel

Gastroenteropancreatic neuroendocrine tumors: new insights in the diagnosis and therapy.

@en

Gastroenteropancreatic neuroendocrine tumors: new insights in the diagnosis and therapy.

@nl

P1433

Q37962416-31768DD8-FE8B-48B0-A645-D39018E10020

P1476

Q37962416-9E95B05A-2E3B-4BD7-94D0-5885374AF0C5

P2093

Q37962416-629938D8-EA3C-4093-9536-D9F6F20E1E9A

Q37962416-E0608B86-A07C-4DE2-84EC-44195FCD6859

P2860

Q37962416-0525A905-5068-4E0F-9C57-F8BE22C6EE72

Q37962416-0ADBE135-4F2B-473E-B7B1-DED127345AA4

Q37962416-0C1A21AB-B0C5-412B-8C91-A85E51ECFDF0

Q37962416-0C1E4608-DF78-48E6-9483-C080359912E3

Q37962416-11F5DFA4-2D12-462C-B1FA-DCFE9F0A0A3F

Q37962416-18218A98-8FEE-4154-AB87-EE67F334B8F2

Q37962416-1A303FEC-0958-4805-A881-DA25C79D26BD

Q37962416-20714739-E6CC-4032-BC1F-3F61E106F601

Q37962416-256208E9-4C78-4D45-9189-8DF1C26339C1

Q37962416-26E89537-E7BF-4F99-AB75-7305F4FC31B5

P2888

Q37962416-B6FE6910-2ADA-40E6-85D6-D9BE7ED832BF

P304

Q37962416-A2C2BBA2-F41F-42AF-917A-783D788DA956

P31

Q37962416-C1B7CCBB-5A84-400B-9CCC-7E0263A1CF51

P356

Q37962416-4AE09E39-CE7A-48D1-903F-DDA7E979AB2F

P433

Q37962416-1848CEE9-1AAD-41A1-8E74-F5A4119CC6B6

P478

Q37962416-B9CFF445-4F0D-4BEE-8271-1C498D066A16

P50

Q37962416-3B8BC8BC-4128-475E-8FED-96BEE1FA6471

Q37962416-83BE3F08-3909-4CA6-9D0D-9CD181F6AE9E

P577

Q37962416-D89CAB6F-C789-45A8-968B-2050AAF11368

P5875

Q37962416-5983B3A1-F29F-459C-8BA8-9BC6B181D775

P698

Q37962416-D7775B3C-7F2B-4459-85AC-E580695B797C

P356

S12020-011-9562-2

P1433

P1476

Gastroenteropancreatic neuroendocrine tumors: new insights in the diagnosis and therapy

@en

P2093

Gregory Kaltsas

http://www.w3.org/2001/XMLSchema#string

Krystallenia I Alexandraki

http://www.w3.org/2001/XMLSchema#string

P2860

Brivanib, a dual FGF/VEGF inhibitor, is active both first and second line against mouse pancreatic neuroendocrine tumors developing adaptive/evasive resistance to VEGF inhibition

New response evaluation criteria in solid tumours: revised RECIST guideline (version 1.1)

Gastroenteropancreatic neuroendocrine tumours

Drug resistance by evasion of antiangiogenic targeting of VEGF signaling in late-stage pancreatic islet tumors

Diffusion MRI: a new strategy for assessment of cancer therapeutic efficacy.

Safety, pharmacokinetic, and antitumor activity of SU11248, a novel oral multitarget tyrosine kinase inhibitor, in patients with cancer.

Treatment of neuroendocrine carcinomas with combined etoposide and cisplatin. Evidence of major therapeutic activity in the anaplastic variants of these neoplasms.

Temozolomide as monotherapy is effective in treatment of advanced malignant neuroendocrine tumors.

Phase I, pharmacokinetic, and pharmacodynamic study of AMG 479, a fully human monoclonal antibody to insulin-like growth factor receptor 1.

Natural history of neuroendocrine enteropancreatic tumors.

P2888

s12020-011-9562-2

P304

40-52

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S12020-011-9562-2

http://www.w3.org/2001/XMLSchema#string

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

41

http://www.w3.org/2001/XMLSchema#string

P50

Krystallenia I Alexandraki

P577

2011-11-29T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

51833952

http://www.w3.org/2001/XMLSchema#string

P698

22124940

http://www.w3.org/2001/XMLSchema#string